Tissue healing efficacy in burn patients treated with 1% silver sulfadiazine versus other treatments: a systematic review and meta-analysis of randomized controlled trials

An Bras Dermatol. 2019 Mar-Apr;94(2):204-210. doi: 10.1590/abd1806-4841.20198321. Epub 2019 May 9.

Abstract

This study aims to evaluate tissue healing efficacy in burn patients treated with 1% silver sulfadiazine versus other treatments. This is a systematic literature review and meta-analysis of randomized clinical trials performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) and PICO strategy, registered in the International Prospective Register of Systematic Reviews (PROSPERO) under the number CRD42017081057. The review found 71 studies in MEDLINE/Pubmed, 1 in Clinical Trials, 19 in the Cochrane Library, and 4 in LILACS in five manual searches. Of these, 81 studies were pre-selected. After independent analysis by two reviewers, only 11 studies met the inclusion criteria for the review. All studies (n = 11) using alternative treatments to silver sulfadiazine were shown to be superior in the mean time for complete wound healing, with statistically significant differences between experimental and control groups (p <0.00001); mean difference (- 4.26), 95% CI [- 5.96, - 2.56].

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Anti-Infective Agents, Local / pharmacology
  • Anti-Infective Agents, Local / therapeutic use*
  • Burns / drug therapy*
  • Hospitalization
  • Humans
  • Randomized Controlled Trials as Topic
  • Silver Sulfadiazine / pharmacology
  • Silver Sulfadiazine / therapeutic use*
  • Time Factors
  • Treatment Outcome
  • Wound Healing* / drug effects

Substances

  • Anti-Infective Agents, Local
  • Silver Sulfadiazine